Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a leading player in the household and personal care industry with a strong international presence and diversified product portfolio. While the company has faced challenges in the North American market, it has seen success in other regions through its dual-brand therapeutic strategy. With a focus on new innovations and cost savings, along with a commitment to diversity and inclusion, Colgate-Palmolive is expected to regain market share and continue its positive growth trajectory.

Bears say

Colgate-Palmolive is facing significant challenges in the North American market. Their self-inflicted pricing issues and under-investment in marketing have led to negative sales and loss of market share to competitors like P&G and Haleon. These issues can be addressed through disruptive innovation and the deployment of a dedicated premium therapeutic brand, as seen in their successful European strategy. However, without these changes, the company may struggle to stabilize in this market. Additionally, Colgate-Palmolive has potential upside in their pet food business and cost-saving initiatives, but their downside scenario valuation is lower than the current stock price.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.